Boston Scientific

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Boston Scientific 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BSX

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. 

CEO
Michael F. Mahoney
CEOMichael F. Mahoney
Employees
53,000
Employees53,000
Headquarters
Marlborough, Massachusetts
HeadquartersMarlborough, Massachusetts
Founded
1979
Founded1979
Employees
53,000
Employees53,000

BSX Key Statistics

Market cap
152.23B
Market cap152.23B
Price-Earnings ratio
56.15
Price-Earnings ratio56.15
Dividend yield
Dividend yield
Average volume
7.47M
Average volume7.47M
High today
$105.10
High today$105.10
Low today
$101.26
Low today$101.26
Open price
$104.51
Open price$104.51
Volume
9.69M
Volume9.69M
52 Week high
$109.50
52 Week high$109.50
52 Week low
$85.98
52 Week low$85.98

Stock Snapshot

As of today, Boston Scientific(BSX) shares are valued at $101.26. The company's market cap stands at 152.23B, with a P/E ratio of 56.15.

During the trading session on 2025-11-14, Boston Scientific(BSX) shares reached a daily high of $105.10 and a low of $101.26. At a current price of $101.26, the stock is 0.0% higher than the low and still -3.7% under the high.

Trading volume for Boston Scientific(BSX) stock has reached 9.69M, versus its average volume of 7.47M.

Over the past 52 weeks, Boston Scientific(BSX) stock has traded between a high of $109.50 and a low of $85.98.

Over the past 52 weeks, Boston Scientific(BSX) stock has traded between a high of $109.50 and a low of $85.98.

BSX News

Nasdaq 7h
Peter Lynch Detailed Fundamental Analysis - BSX

Below is Validea's guru fundamental report for BOSTON SCIENTIFIC CORP (BSX). Of the 22 guru strategies we follow, BSX rates highest using our P/E/Growth Investo...

Peter Lynch Detailed Fundamental Analysis - BSX
Simply Wall St 2d
Is Boston Scientific’s Recent Regulatory Wins Enough to Support Its Rising Share Price?

Wondering if Boston Scientific is a hidden value pick, an overrated star, or something in between? You are in the right place for a straightforward take on what...

Is Boston Scientific’s Recent Regulatory Wins Enough to Support Its Rising Share Price?
Simply Wall St 3d
What Does Boston Scientific's Share Buyback Pause Say About Its Capital Allocation Priorities?

Boston Scientific recently reported that, from July through September 2025, it repurchased zero shares for US$0 million under its previously announced buyback p...

What Does Boston Scientific's Share Buyback Pause Say About Its Capital Allocation Priorities?

Analyst ratings

95%

of 37 ratings
Buy
94.6%
Hold
5.4%
Sell
0%

More BSX News

Nasdaq 4d
Is Boston Scientific a Solid Growth Stock? 3 Reasons to Think "Yes"

Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional...

Is Boston Scientific a Solid Growth Stock? 3 Reasons to Think "Yes"
Simply Wall St 7d
A Look at Boston Scientific’s Valuation Following Breakout Electrophysiology Growth and Expanded FDA Approval

Boston Scientific (BSX) reported strong third-quarter 2025 financial results, with its Electrophysiology division seeing remarkable growth due to the FARAPULSE...

A Look at Boston Scientific’s Valuation Following Breakout Electrophysiology Growth and Expanded FDA Approval

People also own

Based on the portfolios of people who own BSX. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.